Press Releases on May 3, 2021 - EIN Presswire - Press Release Distribution Service

Published on May 3, 2021 - 11:05 GMT

Akoustis Locks Process Flow for Second Wafer Level Package for XBAW Filters

New Packaging Solution Addresses the Small Form Factor Requirements for 5G Mobile and WiFi 6E Devices Packages Will Be Manufactured Both In-House and in Outside Supply Chain to Provide Rapid Prototyping and Flexible Capacity Micro Package Compatible Across …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 3, 2021 - 11:05 GMT

Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE™ for Treatment of Macular Edema Associated with ...

ALPHARETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 3, 2021 - 11:05 GMT

Cabaletta Bio Reports First Quarter 2021 Financial Results and Provides New Pipeline Updates

– Acute safety data from the first cohort in the DesCAARTes™ trial announced today; no dose limiting toxicities (DLTs) or clinically relevant adverse events observed in the first dose cohort as of April 30, 2021 – – PLA2R-CAART announced as a new …

Distribution channels:

Published on May 3, 2021 - 11:05 GMT

Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp

SALT LAKE CITY, May 03, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced that it has entered into a definitive agreement to sell select operating assets and intellectual property ( …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 3, 2021 - 11:05 GMT

Revolution Medicines Highlights Slate of Diverse Board of Directors Nominees for Upcoming 2021 Annual Shareholder Meeting

REDWOOD CITY, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, today highlights the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 3, 2021 - 11:05 GMT

Fission Uranium Corp. Announces $30 Million Bought Deal Public Offering of Units

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. KELOWNA, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) -- FISSION URANIUM CORP. ("FISSION" or the "Company") is pleased to announce that it has …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry

Published on May 3, 2021 - 11:05 GMT

Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products

TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product …

Distribution channels: